Kuros Biosciences AG
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
13.26.18N/AN/A
Price/Sales ratio
0.600.460.430.37
Earnings per Share (EPS)
CHF0.15CHF0.32N/AN/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.200.13-5.63-5.55-2.05-3.73-4.26-8.37-3.41-9.30-0.01-2.05
Price/Sales ratio
7.090.13104.95171.5233.6416.4212.164.562.773.800.3516.42
Price/Book Value ratio
-0.271.232.901.250.310.540.580.820.722.250.000.54
Price/Cash Flow ratio
-0.29-0.32-12.52-8.57-1.87-3.87-5.31-11.57-6.78-14.43-0.01-1.87
Price/Free Cash Flow ratio
-0.29-0.32-12.45-7.47-1.78-3.83-5.19-10.83-6.43-13.92-0.01-1.78
Price/Earnings Growth ratio
0.020.000.050.130.050.080.140.16-0.030.790.030.08
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-910.10%91.14%-645.42%-518.91%-377.76%-3.08%41.37%72.86%59.87%71.31%100%-377.76%
Operating Profit Margin
-1893.7%10.29%-2011.87%-3041.76%-1919.86%-444.82%-289.15%-63.46%-74.75%-39.30%-2326.6%-444.82%
Pretax Profit Margin
-3402.60%97.98%-1911.12%-3107.30%-1931.88%-461.65%-299.43%-69.15%-88.90%-39.76%-3082.5%-461.65%
Net Profit Margin
-3402.60%97.98%-1860.88%-3086.89%-1635.38%-439.35%-285.21%-54.58%-81.14%-40.89%-3082.5%-439.35%
Effective Tax Rate
-0.58%-0.73%2.62%0.65%15.34%4.82%4.74%21.06%8.72%-2.84%N/A4.82%
Return on Assets
-192.98%191.07%-45.11%-19.14%-13.62%-12.80%-12.20%-8.25%-17.59%-19.20%-37.16%-12.80%
Return On Equity
129.77%930.79%-51.52%-22.53%-15.28%-14.45%-13.61%-9.79%-21.19%-24.20%-40.56%-14.45%
Return on Capital Employed
72.22%41.84%-52.70%-19.94%-16.78%-13.52%-12.90%-10.95%-19.11%-22.63%-33.06%-13.52%
Liquidity Ratios
Current Ratio
0.401.874.103.794.906.398.76N/AN/AN/A2.496.39
Quick Ratio
0.401.874.013.744.776.138.382.752.241.691.916.13
Cash ratio
0.381.233.783.584.535.717.322.531.911.071.915.71
Days of Sales Outstanding
N/AN/A105.95105.26109.24108.1793.6244.6773.4282.83N/A108.17
Days of Inventory outstanding
N/A0.0012.7324.2958.44131.89225.04171.06160.32184.09N/A131.89
Operating Cycle
N/A0.00118.69129.55167.69240.07318.66215.73233.74266.92N/A240.07
Days of Payables Outstanding
5.49420.1058.74145.77172.13146.41144.2782.3665.8449.32N/A146.41
Cash Conversion Cycle
-5.49-420.1059.94-16.22-4.4493.65174.39133.37167.89217.60N/A-4.44
Debt Ratios
Debt Ratio
2.131.13N/AN/AN/AN/AN/AN/AN/AN/A0.16N/A
Debt Equity Ratio
-1.435.52N/AN/AN/AN/AN/AN/AN/AN/A0.20N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/A
Total Debt to Capitalization
3.300.84N/AN/AN/AN/AN/AN/AN/AN/A0.02N/A
Interest Coverage Ratio
N/AN/AN/A-35.74-108.94-17.49-13.77N/AN/AN/A-12.85-108.94
Cash Flow to Debt Ratio
-0.63-0.68N/AN/AN/AN/AN/AN/AN/AN/A-10.02N/A
Company Equity Multiplier
-0.674.871.141.171.121.121.111.181.201.261.201.12
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-23.75-0.39-8.38-19.99-17.95-4.23-2.28-0.39-0.40-0.26-19.17-4.23
Free Cash Flow / Operating Cash Flow Ratio
1.0011.001.141.051.011.021.061.051.031.001.01
Cash Flow Coverage Ratio
-0.63-0.68N/AN/AN/AN/AN/AN/AN/AN/A-10.02N/A
Short Term Coverage Ratio
-0.63-0.68N/AN/AN/AN/AN/AN/AN/AN/A-46.08N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A